Nabumetone
Back to searchMolecule Structure
Scientific Name
Nabumetone
Description of the Drug
Nabumetone is an NSAID used to treat osteoarthritis and rheumatoid arthritis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00461
http://www.drugbank.ca/drugs/DB00461
Brand Name(s)
Nabumetone, Relafen, Relifex
Company Owner(s)
Nostrum Laboratories Inc, Smithkline Beecham Corp Dba Glaxosmithkline, Oxford Pharmaceuticals Llc, Copley Pharmaceutical Inc, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Chartwell Rx Sciences Llc, Epic Pharma Inc, Lgm Pharma Solutions Llc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cyclooxygenase-2 | SINGLE PROTEIN | INHIBITOR | CHEMBL230 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2256 | |
PharmGKB | PA450572 | |
Human Metabolome Database | HMDB0014604 | |
DrugBank | DB00461 | |
PubChem: Thomson Pharma | 15196152 | |
PubChem | 4409 | |
LINCS | LSM-3453 | |
Nikkaji | J16.442I | |
PDBe | NBO | |
BindingDB | 40128 | |
EPA CompTox Dashboard | DTXSID4045472 | |
DrugCentral | 1863 | |
Brenda | 18650 | 192934 |
ChemicalBook | CB2386779 | |
Guide to Pharmacology | 7245 | |
rxnorm | NABUMETONE | RELAFEN |
PubChem: Drugs of the Future | 12012677 | |
ChEBI | 7443 | |
ZINC | ZINC000000020221 |